Episode Details

A Korean study found that anaphylaxis recurrence, affecting 15.6% of cases, is driven by socioeconomic factors and comorbidities, calling for targeted interventions. Australian data revealed a sharp rise in melanoma-related deaths for tumors 0.8–1.0 mm thick, suggesting a need for stricter monitoring and management for these patients. Lastly, the experimental drug BNC210 showed early promise in reducing PTSD symptoms, with significant improvements in both PTSD and depressive symptoms, though sleep benefits were minimal.